If you purchased or paid for eligible generic prescription drugs in the United States between May 1, 2009 and December 31, 2019, you may be eligible to receive compensation from multiple court-approved antitrust settlements with a combined total value of approximately $533,000,000 thus far, depending on the drugs purchased and the settlement(s) for which you may qualify.
About
The settlements stems from a long-running federal antitrust class action (In re Generic Pharmaceuticals Pricing Antitrust Litigation, Case No. 16-MD-2724) in the U.S. District Court for the Eastern District of Pennsylvania. End-payers — meaning consumers, insurers, employer health plans, and other entities that paid for or reimbursed prescription generic drugs — alleged that a group of generic drug manufacturers engaged in illegal collusion to artificially inflate prices of certain generic medications sold in the U.S. from May 1, 2009 through December 31, 2019.
What the Lawsuit Claims
Plaintiffs claim that the defendant companies conspired (i.e., coordinated conduct) in violation of federal and state antitrust laws and consumer protection statutes. The allegation is not about drug safety or effectiveness — it’s about pricing conduct: that competition was suppressed and prices for specific generic drugs were kept higher than they would have been in a truly competitive market.
The Settlement Funds & Who’s Included
A settlement class has been certified for each of the end-payer settlements approved by the court. If, during the class period (2009–2019), you paid for or were reimbursed for one or more of the generic drugs at issue in this litigation, you may be a Settlement Class Member. The settlement class definitions and the list of eligible drugs (many dozens) is contained in the settlement notices posted on the official settlement site www.GenericDrugsEndPayerSettlement.com.
Being a class member does not require proof of wrongdoing by the defendants — they have generally denied liability — but it may qualify you for a potential share of settlement money if you file a proper claim.
Disclaimer
The claims process has not yet commenced, and no claims filing deadline exists. Macmoor Capital is an independent third-party claims management firm. We are not Attorneys, We are not affiliated with the Court, the Claims Administrator, or Class Counsel. You do not need to sign up with a third-party claims recovery service provider (like Macmoor Capital) to file a claim for settlement benefits and you do not need to pay a share of your settlement recoveries to any provider. Claimants may file for settlement benefits directly at no cost. For more information please visit our website (www.macmoor.com) or the official court approved settlement website for this case www.GenericDrugsEndPayerSettlement.com, where you can register to be notified when the claims process begins. You may also call the Settlement Administrator at 1-877-316-0171 or email info@GenericDrugsEndPayerSettlement.com.
How Macmoor Capital Can Help
Navigating the claims process can be complex and time-consuming. Macmoor Capital specializes in class action settlements and provides end-to-end assistance to maximize your recovery:
- Eligibility Assessment: We’ll review your organization’s records to determine eligibility
- Documentation Collection: Our team will gather and compile all required data, including reimbursement records and claim histories.
- Claim Filing: We handle the submission process, ensuring compliance with settlement guidelines.
- Follow-Up: We work with claims administrators to monitor the progress of your claim and address any disputes.
- Recovery Optimization: Our expertise ensures that your organization receives the maximum settlement amount.
Next Steps
Contact us today to schedule a free consultation and determine your eligibility:
Email: info@macmoor.com
Phone: +1-786-638-6006
Website: www.macmoor.com
Please Note: Macmoor Capital works exclusively with corporate and institutional clients, including self-funded employers and third-party payers. Our services are designed for organizations with complex claims data environments. We do not represent or solicit individual consumers.
Let Macmoor Capital guide you through this process and ensure you receive the compensation you deserve.
Our Services
Macmoor Capital focuses on making sure to maximize every client's claim. Every year, thousands of businesses fail to recover damages incurred because they neglect to file class action claims to receive their share of multi-million and multi-billion dollar class action lawsuit settlements.
